Renovia Inc., a healthcare based investment firm has only been in operation for two years as it was established on August 2016. Nevertheless, in its two years of existence, the firm has marked milestones that companies which have been in play longer than that, aren’t even close to accomplishing. Its success can be attributed to its great leaders, led by Marc Beer.
Profitable investments that impact the lives of others positively
Having been in the healthcare sector all his life, Marc Beer boasts vast experience in the field of biotechnology, pharmaceuticals and several other areas of MedTech. This has helped him identify some of the most profitable areas to venture in, and this when combined by the many networking connections he boasts, has enabled him turn many of Renovia’s goals into a reality. It’s also essential to note that these investments benefit not only him, but impact the rest of the world positively as well.
For instance, under his direction, and that of the other two founding members of Renovia Inc., namely; Yolanda Lorie and Ramon Iglesias, Renovia Inc developed the first pelvic training device known as Leva. The primary objective for the development of the leva device is to improve the lives of more than 250 million women who suffer from pelvic disorders such as urinary incontinence after childbirth.
Marc Beer does it again
Marc Beer has once again brought triumph to Renovia Inc. after he led the company to secure a whopping $42.3 million, during its series B round founding. Again he achieved this through his top-shelf networking abilities. Once again the funding was inclusive of A-list healthcare investment firms such as Longwood, Ascension ventures, New York perceptive advisors and many others.
The primary purpose of the funding is to facilitate the development of a new generation Leva device which will further curb the prevalence of pelvic disorders. The funds will also be channeled to the development of three more diagnostic and therapeutic products which again, will help shape the health industry.
More insight into Marc Beer
Marc Beer has been at the helm of medical technology for more than two years now. His innovative skills when it comes to ground-breaking biotech and pharmaceutical developments has seen him be part of multiple MedTech giants. For instance, in his over 25 years career, Marc has served as Vice president of Genzyme’s global marketing team, where he helped facilitate the launch of products that address rare diseases. He was also an executive member of Erytech Pharma’s board of directors and also worked at Abbot Pharmaceuticals.
Marc Beer is also the man behind Viacell, a biotech company he established in 2000. As an alumnus of The University of Miami (Oxford OH), Marc Beer has accomplished a lot, and it seems he is not done transforming the healthcare sector yet. Learnb more: https://people.equilar.com/bio/marc-beer-aegerion-pharmaceuticals-/salary/78453